Bioplattern analysis and subject-specific diagnosis and care of dementia

被引:3
作者
Ifeachor, E. C.
Henderson, G. T.
Goh, C.
Wimalaratna, H. S. K.
Hudson, N.
机构
来源
2005 27TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-7 | 2005年
关键词
EEG; dementia; Alzheimer's disease; fractal dimension; zero crossing distribution; biopattern; bioprofile;
D O I
10.1109/IEMBS.2005.1616974
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Worldwide, the number of people that develop Alzheimer's disease and other types of dementia is rapidly rising and will create a considerable financial burden on the health and social services. The availability of new drugs that may slow or even halt the disease progression makes accurate early detection crucial. Objective methods are needed to support clinical diagnosis and care for patients; to quantify severity, monitor progression and response to new treatments. Electrophysiological markers have an important role to play in the objective assessment and care for dementia. The EEG provides a measure of brain dysfunction and EEG changes could be detected fairly early in the dementing process. Subject-specific EEG analysis offers the possibility of using objective methods to assess and care for dementia on an individual basis. The main objectives of this paper are: (i) to introduce the concepts of subject-specific EEG analysis as a basis for improving diagnosis and care for dementia; and (ii) present two novel methods for deriving suitable subject-specific electrophysiological markers - analysis of fractal dimension and zero crossing interval density of the EEG. We present findings that indicate that the methods are potentially good candidates for the development of individualized, low-cost, easy to administer and reasonably accurate methods for detecting dementia within the growing at risk population.
引用
收藏
页码:2490 / 2493
页数:4
相关论文
共 13 条
  • [1] Genomic characterization of Alzheimer's disease and genotype-related phenotypic analysis of biological markers in dementia
    Cacabelos, R
    [J]. PHARMACOGENOMICS, 2004, 5 (08) : 1049 - 1105
  • [2] HENDERSON GT, 2002, P 4 INT WORKSH BIOSI, P319
  • [3] Epidemiology of dementia and Alzheimer's disease
    Hendrie, HC
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 1998, 6 (02) : S3 - S18
  • [4] IFEACHOR EC, 2004, P 26 ANN INT C IEE E
  • [5] Practice parameter: Diagnosis of dementia (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
    Knopman, DS
    DeKosky, ST
    Cummings, JL
    Chui, H
    Corey-Bloom, J
    Relkin, N
    Small, GW
    Miller, B
    Stevens, JC
    [J]. NEUROLOGY, 2001, 56 (09) : 1143 - 1153
  • [6] KTONAS PY, 1983, CRIT REV BIOMED ENG, V9, P39
  • [7] KURZ A, 1998, CLINICIAN, V16, P7
  • [8] Individual analysis of EEG frequency and band power in mild Alzheimer's disease
    Moretti, DV
    Babiloni, C
    Binetti, G
    Cassetta, E
    Dal Forno, G
    Ferreric, F
    Ferri, R
    Lanuzza, B
    Miniussi, C
    Nobili, F
    Rodriguez, G
    Salinari, S
    Rossini, PM
    [J]. CLINICAL NEUROPHYSIOLOGY, 2004, 115 (02) : 299 - 308
  • [9] *NIH, 2003, RES ADV NIH 2003 PRO
  • [10] World population and health in transition
    Raleigh, VS
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1999, 319 (7215): : 981 - 984